|
1
|
Watson N, Divers R, Kedar R, Mehindru A,
Mehindru A, Borlongan MC and Borlongan CV: Discarded Wharton jelly
of the human umbilical cord: A viable source for mesenchymal
stromal cells. Cytotherapy. 17:18–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li DR and Cai JH: Methods of isolation,
expansion, differentiating induction and preservation of human
umbilical cord mesenchymal stem cells. Chin Med J (Engl).
125:4504–4510. 2012.PubMed/NCBI
|
|
3
|
Li T, Xia M, Gao Y, Chen Y and Xu Y: Human
umbilical cord mesenchymal stem cells: An overview of their
potential in cell-based therapy. Expert Opin Biol Ther.
15:1293–1306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang H, Xie Z, Wei Z, Yang H, Yang S, Zhu
Z, Wang P, Zhao C and Bi J: Human umbilical cord mesenchymal stem
cell-derived neuron-like cells rescue memory deficits and reduce
amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem
Cell Res Ther. 4:762013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui B, Li E, Yang B and Wang B: Human
umbilical cord blood-derived mesenchymal stem cell transplantation
for the treatment of spinal cord injury. Exp Ther Med. 7:1233–1236.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santos Nascimento D, Mosqueira D, Sousa
LM, Teixeira M, Filipe M, Resende TP, Araújo AF, Valente M, Almeida
J, Martins JP, et al: Human umbilical cord tissue-derived
mesenchymal stromal cells attenuate remodeling after myocardial
infarction by proangiogenic, antiapoptotic, and endogenous
cell-activation mechanisms. Stem Cell Res Ther. 5:52014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang G, Li Y, Wang Y, Dong Y, Wang FS,
Ding Y, Kang Y and Xu X: Roles of the co-culture of human umbilical
cord Wharton's jelly-derived mesenchymal stem cells with rat
pancreatic cells in the treatment of rats with diabetes mellitus.
Exp Ther Med. 8:1389–1396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Qian H, Zhu W, Zhang X, Yan Y, Ye
S, Peng X, Li W and Xu W: Hepatocyte growth factor modification
promotes the amelioration effects of human umbilical cord
mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev.
20:103–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Min F, Gao F, Li Q and Liu Z: Therapeutic
effect of human umbilical cord mesenchymal stem cells modified by
angiotensin-converting enzyme 2 gene on bleomycin-induced lung
fibrosis injury. Mol Med Rep. 11:2387–2396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee S, Choi E, Cha MJ and Hwang KC: Cell
adhesion and long-term survival of transplanted mesenchymal stem
cells: A prerequisite for cell therapy. Oid Med Cell Longev.
2015:6329022015.
|
|
11
|
Tsutsumi S, Shimazu A, Miyazaki K, Pan H,
Koike C, Yoshida E, Takagishi K and Kato Y: Retention of
multilineage differentiation potential of mesenchymal cells during
proliferation in response to FGF. Biochem Biophys Res Commun.
288:413–419. 2011. View Article : Google Scholar
|
|
12
|
Chieregato K, Castegnaro S, Madeo D,
Astori G, Pegoraro M and Rodeghiero F: Epidermal growth factor,
basic fibroblast growth factor and platelet-derived growth
factor-bb can substitute for fetal bovine serum and compete with
human platelet-rich plasma in the ex vivo expansion of mesenchymal
stromal cells derived from adipose tissue. Cytotherapy. 13:933–943.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huat TJ, Khan AA, Pati S, Mustafa Z,
Abdullah JM and Jaafar H: IGF-1 enhances cell proliferation and
survival during early differentiation of mesenchymal stem cells to
neural progenitor-like cells. BMC Neurosi. 15:912014. View Article : Google Scholar
|
|
14
|
Bertrand FE, Steelman LS, Chappell WH,
Abrams SL, Shelton JG, White ER, Ludwig DL and McCubrey JA: Synergy
between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR
pathway inhibitors in suppressing IGF-1R-mediated growth in
hematopoietic cells. Leukemia. 20:1254–1260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau MT and Leung PC: The PI3K/Akt/mTOR
signaling pathway mediates insulin-like growth factor 1-induced
E-cadherin down-regulation and cell proliferation in ovarian cancer
cells. Cancer Lett. 326:191–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao Y, Zhou X, Liang C, Li H, Han B, Li F
and Chen Q: TGF-β3 and IGF-1 synergy ameliorates nucleus pulposus
mesenchymal stem cell differentiation towards the nucleus pulposus
cell type through MAPK/ERK signaling. Growth Factors. 33:326–336.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang X, Wei A, Liu Y, He G, Zhou Z and Yu
Z: IGF-1 protects retinal ganglion cells from hypoxia-induced
apoptosis by activating the Erk-1/2 and Akt pathways. Mol Vis.
19:1901–1912. 2013.PubMed/NCBI
|
|
18
|
Zhu SF, He YL and Fu XF: Biological
features and ultrastructure of human umbilical cord mesenchymal
stem cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 33:382–386.
2011.(In Chinese). PubMed/NCBI
|
|
19
|
Yamahara K, Harada K, Ohshima M, Ishikane
S, Ohnishi S, Tsuda H, Otani K, Taguchi A, Soma T, Ogawa H, et al:
Comparison of angiogenic, cytoprotective, and immunosuppressive
properties of human amnion- and chorion-derived mesenchymal stem
cells. PLoS One. 9:e883192014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shalaby RH, Rashed LA, Ismaail AE, Madkour
NK and Elwakeel SH: Hematopoietic stem cells derived from human
umbilical cord ameliorate cisplatin-induced acute renal failure in
rats. Am J Stem Cells. 3:83–96. 2014.PubMed/NCBI
|
|
21
|
Imberti B, Morigi M, Tomasoni S, Rota C,
Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J,
et al: Insulin-like growth factor-1 sustains stem cell mediated
renal repair. J Am Soc Nephrol. 18:2921–2928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morigi M, Introna M, Imberti B, Corna D,
Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, et al:
Human bone marrow mesenchymal stem cells accelerate recovery of
acute renal injury and prolong survival in mice. Stem Cells.
26:2075–2082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Granero-Moltó F, Myers TJ, Weis JA,
Longobardi L, Li T, Yan Y, Case N, Rubin J and Spagnoli A:
Mesenchymal stem cells expressing insulin-like growth factor-I
(MSCIGF) promote fracture healing and restore new bone formation in
Irs1 knockout mice: Analyses of MSCIGF autocrine and paracrine
regenerative effects. Stem Cells. 29:1537–1548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang F, Hong Y, Liang W, Ren T, Jing S
and Lin J: Co-culture with Sertoli cells promotes proliferation and
migration of umbilical cord mesenchymal stem cells. Biochem Biophys
Res Commun. 427:86–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang G, Gurtu V, Kain SR and Yan G: Early
detection of apoptosis using a fluorescent conjugate of annexin V.
Biotechniques. 23:525–531. 1997.PubMed/NCBI
|
|
26
|
Wang J, Zheng T, Chen X, Song X, Meng X,
Bhatta N, Pan S, Jiang H and Liu L: MDM2 antagonist can inhibit
tumor growth in hepatocellular carcinoma with different types of
p53 in vitro. J Gastroenterol Hepatol. 26:371–377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding DC, Chang YH, Shyu WC and Lin SZ:
Human umbilical cord mesenchymal stem cells: A new era for stem
cell therapy. Cell Transplant. 24:339–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashare A, Nymon AB, Doerschug KC, Morrison
JM, Monick MM and Hunnighake GW: Insulin-like growth factor-1
improves survival in sepsis via enhanced hepatic bacterial
clearance. Am J Respir Crit Care Med. 178:149–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Galvan V, Logvinova A, Sperandio S, Ichijo
H and Bredesen DE: Type 1 insulin-like growth factor receptor
(IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1
(ASK1). J Biol Chem. 278:13325–13332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shelton JG, Steelman LS, White ER and
McCubrey JA: Synergy between PI3K/Akt and Raf/MEK/ERK pathways in
IGF-1R mediated cell cycle progression and prevention of apoptosis
in hematopoietic cells. Cell Cycle. 3:372–379. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang G, Feng CC, Chu SJ, Zhang R, Lu YM,
Zhu JS and Zhang J: Toosendanin inhibits growth and induces
apoptosis in colorectal cancer cells through suppression of
AKT/GSK-3β/β-catenin pathway. Int J Oncol. 47:1767–1774. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Park ES, Kang DH, Yang MK, Kang JC, Jang
YC, Park JS, Kim SK and Shin HS: Cordycepin, 3′-deoxyadenosine,
prevents rat hearts from ischemia/reperfusion injury via activation
of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Cardiovasc Toxicol. 14:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Khaidakov M, Ding Z, Dai Y,
Mercanti F and Mehta JL: LOX-1 in the maintenance of cytoskeleton
and proliferation in senescent cardiac fibroblasts. J Mol Cell
Cardiol. 60:184–190. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chou MM, Masuda-Robens JM and Gupta ML:
Cdc42 promotes G1 progression through p70 S6 kinase-mediated
induction of cyclin E expression. J Biol Chem. 278:35241–35247.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Resnitzky D, Gossen M, Bujard H and Reed
SI: Acceleration of the G1/S phase transition by expression of
cyclins D1 and E with an inducible system. Mol Cell Biol.
14:1669–1679. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms, and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
